Evaluation of lung function imaging biomarkers from MRI during the convalescent phase of COVID-19 infection in a monocentric cohort

Evaluation of lung function imaging biomarkers from MRI during the convalescent phase of COVID-19 infection in a monocentric cohort - NAP-HAP-Lung

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032159

Enrollment

150

Registered

2023-10-24

Start date

2023-11-02

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long-COVID

Interventions

Group 1: Retrospective analysis of data NAPKON HAP data to LMU Klinikum München in already anonymized form. The following data were requested as part of the data use request - release has already bee

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: have undergone one or more cardiac MRI examinations in our clinic after the detection of COVID-19 (PCR-test)

Exclusion criteria

Exclusion criteria: Patients without an existing cardiac MRI examination Absence of evidence of COVID-19 disease

Design outcomes

Primary

Measure	Time frame
Correlation of structural and functional MRI image parameters of the lung to clinical pulmonary function test results.	—

Secondary

Measure	Time frame
Comparison of progression of MR findings with progression of findings from clinical pulmonary function tests over time. Comparison of different MRI sequences with each other to determine the most appropriate method for lung imaging according to COVID-19.	—

Countries

Germany

Contacts

Public ContactJudith Spiro

LMU München

judith.spiro@med.uni-muenchen.de+4989440076642

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026